Serum Institute's Cervavac vaccine receives WHO prequalification

AI Summary

Serum Institute of India’s Cervavac, India’s first indigenously developed HPV vaccine, has received World Health Organization prequalification. The designation supports its eligibility for procurement by international agencies and global immunization programs.

Pune: India’s first indigenously developed Human Papillomavirus (HPV) vaccine, Cervavac, manufactured by the Serum Institute of India (SII), received...